Research Topic · Peer-Reviewed

Hematopoietic Progenitor Cells

Hematopoietic progenitor cells (HPCs) are immature cells that have the potential to form a variety of blood cells. These cells are essential for normal blood formation and the production of red and white blood cells. HPCs are found in the bone marrow and have been used in regenerative medicine to treat diseases such…

Curated from this journal's research 📚 1 peer-reviewed article cited 🗓 Reviewed June 2026

Overview

Hematopoietic progenitor cells (HPCs) are immature cells that have the potential to form a variety of blood cells. These cells are essential for normal blood formation and the production of red and white blood cells. HPCs are found in the bone marrow and have been used in regenerative medicine to treat diseases such as anemia, leukemia, and some forms of cancer. They have also been used to regenerate tissues such as skin and heart muscle. HPCs are also being studied for their potential use in gene therapy, immunotherapy and stem cell therapy. They offer hope for treating a variety of diseases and conditions and may be able to provide new treatments for a range of conditions.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

Editorial oversight

Curated from peer-reviewed research published in Bone Marrow Biology.

Journal editorial board
Azad Saei · Sweden Shanmuganathan Chandrakasan · United States Sadanand Fulzele · United States

This page summarises published research for orientation; it is not medical or professional advice.